Results 21 to 30 of about 3,550,191 (258)

Impacts of Quarterly Sow Mass Vaccination with a Porcine Reproductive and Respiratory Syndrome Virus Type 1 (PRRSV-1) Modified Live Vaccine in Two Herds

open access: yesVaccines, 2021
In recent years, there has been a considerable increase in the use of Modified Live PRRSV Vaccines (MLV) for mass vaccination in Denmark. The potential risks and negative impact of this strategy have been sparsely studied.
Kasper Pedersen   +3 more
doaj   +1 more source

Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar [PDF]

open access: yes, 2012
BACKGROUND: The World Health Organization (WHO) recommends oral cholera vaccines (OCVs) as a supplementary tool to conventional prevention of cholera. Dukoral, a killed whole-cell two-dose OCV, was used in a mass vaccination campaign in 2009 in Zanzibar.
Claire-Lise Chaignat   +31 more
core   +1 more source

The COVID-19 Vaccination Strategy in Brazil—A Case Study

open access: yesEpidemiologia, 2021
Brazil is among the countries which have faced two devastating infection waves of COVID-19 in the past year. Despite the fact the country has one of the world’s leading immunization programs, Brazil only slowly established a national COVID-19 vaccination
Llanos Bernardeau-Serra   +5 more
doaj   +1 more source

Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar [PDF]

open access: yes, 2012
BACKGROUND: Recent research in two cholera-endemic communities of Zanzibar has shown that a majority (?94%) of the adult population was willing to receive free oral cholera vaccines (OCVs). Since OCV uptake in the 2009 campaign reached only ?50% in these
Claire-Lise Chaignat   +26 more
core   +1 more source

Targeting vaccination against novel infections : risk, age and spatial structure for pandemic influenza in Great Britain [PDF]

open access: yes, 2011
The emergence of a novel strain of H1N1 influenza virus in Mexico in 2009, and its subsequent worldwide spread, has focused attention to the question of optimal deployment of mass vaccination campaigns.
White, Peter, Keeling, Matthew James
core   +1 more source

School nurses' experiences of delivering the UK HPV vaccination programme in its first year [PDF]

open access: yes, 2011
Background: In the United Kingdom (UK) in September 2008, school nurses began delivering the HPV immunisation programme for girls aged 12 and 13 years old. This study offers insights from school nurses' perspectives and experiences of delivering this new
Hilton, S.   +15 more
core   +2 more sources

Controlling Human Rabies: The Development of an Effective, Inexpensive and Locally Made Passive Cooling Device for Storing Thermotolerant Animal Rabies Vaccines

open access: yesTropical Medicine and Infectious Disease, 2020
Thermotolerant vaccines greatly improved the reach and impact of large-scale vaccination programs to eliminate diseases such as smallpox, polio and rinderpest.
Ahmed Lugelo   +4 more
doaj   +1 more source

Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania [PDF]

open access: yes, 2012
Canine vaccination has been successful in controlling rabies in diverse settings worldwide. However, concerns remain that coverage levels which have previously been sufficient might be insufficient in systems where transmission occurs both between and ...
Alison P. Galvani (42462)   +23 more
core   +1 more source

Social and cultural features of vaccine acceptance and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar [PDF]

open access: yes, 2012
Classical cholera control is based on prevention—safe water, sanitation and education of people on the importance of hygiene and diarrheal diseases—health system preparedness and a timely response to provide appropriate treatment in the event of an ...
Schätti Zundel, Christian
core   +1 more source

The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines

open access: yes, 2021
The global drive to vaccinate against severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) began in December 2020 with countries in Europe, Middle East, and North America leading the roll out of a mass-vaccination program.
Beardsley, Justin   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy